Yarbrough Capital, LLC Neurocrine Biosciences Inc Transaction History

Yarbrough Capital, LLC

  • $2.58 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 12, 2023
SELL
$106.72 - $127.06 $115,471 - $137,478
-1,082 Reduced 38.7%
1,714 $0
Q2 2022

Jul 08, 2022
SELL
$75.79 - $100.07 $61,162 - $80,756
-807 Reduced 22.4%
2,796 $273,000
Q1 2022

Apr 14, 2022
BUY
$72.45 - $94.81 $58,467 - $76,511
807 Added 28.86%
3,603 $338,000
Q4 2021

Feb 01, 2022
BUY
$79.65 - $106.22 $222,701 - $296,991
2,796 New
2,796 $238,000

Others Institutions Holding NBIX

# of Institutions
654
Shares Held
96.5M
Call Options Held
282K
Put Options Held
281K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.4B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Yarbrough Capital, LLC Portfolio

Follow Yarbrough Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yarbrough Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yarbrough Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email